NAT10 and diffuse large B-cell lymphoma: Lentivirus‐mediated RNA interference vectors targeting NAT10 were further established in DLBCL cells, of which shNAT10#2 (NAT10 knockdown, NAT10 KD) exhibited the highest efficacy (Figure 2H,I) and was selected for subsequent functional experiments.